Dexametasona transtimpánica en hipoacusia súbita neurosensorial tardía
Contenido principal del artículo
Resumen
La hipoacusia súbita neurosensorial (HSNS), definida como una pérdida auditiva abrupta en menos de tres días de más de 30 dB sin ninguna causa justificable, es uno de las urgencias otológicas que paradójicamente carece de un tratamiento consensuado. Su etiología se atribuye a una inflamación por infección viral, o bien, de tipo vascular.
Detalles del artículo
Sección
Cómo citar
Referencias
Gionoli GJ, Li JC. Transtympanic steroid for sudden hearing loss. Otolaryngol Head and Neck Surg 2001; 125(3): 142-6.
Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden hearing loss. Am J Otolaryngol 1999; 20(5): 587-92.
Guan-Min H, Hung-Ching L, Min-Tsan S. Effectiveness of intratympanic dexametasona injection in sudden-deaf patient as salvage treatment. Laringoscope 2004; 114(7): 1184-9.
Hashisaki GT. Sudden sensory hearing loss. In: Byron J, Bailey MD, et al. (eds.). Otolaryngology Head and Neck Surgery. 3rd Ed. Lippincott Williams & Wilkins; 2001, p. 1919-23.
Cummings, et al. (eds.). Otolaryngology: Head and Neck Surgery. Arts HA. Differential diagnosis of sensorineural hearing loss. 3rd Ed. Charles W; 1999, p. 2908-29.
Kopke RD, Hoffer ME, Wester D, Oleary MJ. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22(4): 475-9.
Doyle KJ, Bauch C, Battista R, Beatty CH, Hughes GB, Mason J, et al. Intratympanic steroid treatment: A Review. Otol Neurotol 2004; 25:
-39.
Gustafson LM, Pensak ML. Inner ear perfusion therapy: an up date. Cur Opinion in Head and Neck Surgery 2000; 8: 398-402.
Hillman TM, Arriaga MA, Chen DA. Intratympanic Steroid: Do they acutely improve hearing in cases of cochlear hydrops. Laryngoscope 2003; 113: 1903-07.
Chandrasekhar SS. Intratympanic dexametasona for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol
; 22: 18-23.
Sebastián G. Medida de la palabra hablada. Audiología práctica. 4ta Ed. Buenos Aires: Editorial Médica Panamericana; 1992, p.
-72.
Furuhashi A, Matsuda K, Asahi K, Nakashima T. Sudden deafness. Long term fallow-up and recurrence. Clin Otolaryngol 2002; 27:
-63.
Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in Treatment of idiopathic sudden hearing loss. Otol Neurotol 2003;
: 572-5.
Schweinfurth JM, Cacace AT, Parnes SM. Clinical applications of otoacustic emissions in sudden hearing loss. Laryngoscope 1997; 107:
-63.
Yanagita N, nakashima T, Ohno Y, Kanzaki J, Shitara T. Estimated annual number of patient treated for sensorineural hearing loss in Japan. Acta Otolaryngol 1994; 514: 9-13.
Wilkins SA, Mattox DE, Lyles A. Evaluation of a Shotgun regimen for sudden hearing loss. Otolaryngol Head Neck Surg 1987; 97:
-80.
Uri N, Doweck I, Cohen-Kerem R, Greenberg E. Acyclovir in treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2003; 128: 544-9.